Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma

NCT05214222 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Advanced Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Anlotinib/Penpulimab/Chemotherapy
DRUG: Penpulimab/Chemotherapy

Sponsor

Nanfang Hospital, Southern Medical University